Histone acetylation: a key determinant of acquired cisplatin resistance in cancer
Abstract Cisplatin is an alkylating class of chemotherapeutic drugs used to treat cancer patients. However, cisplatin fails in long-term treatment, and drug resistance is the primary reason for tumor recurrence. Hence, understanding the mechanism of acquirement of chemoresistance is essential for de...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2024-01-01
|
| Seri Bilgileri: | Clinical Epigenetics |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13148-023-01615-5 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|